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Abstract
Aim—The goal of this investigation was to determine whether epigenetic modifications in the
IFNG promoter are associated with an increase of IFNG transcription in different stages of
periodontal diseases.
Materials and Methods—DNA was extracted from gingival biopsy samples collected from 47
total sites from 47 different subjects: 23 periodontally healthy sites, 12 experimentally induced
gingivitis sites and 12 chronic periodontitis sites. Levels of DNA methylation within the IFNG
promoter containing six CpG dinucleotides were determined using pyrosequencing technology.
Interferon gamma mRNA expression was analysed by quantitative polymerase chain reactions
using isolated RNA from part of the biological samples mentioned above.
Results—The methylation level of all six analysed CpG sites within the IFNG promoter region
in the periodontitis biopsies {52% [interquartile range, IQR (43.8%, 63%)]} was significantly
lower than periodontally healthy samples {62% [IQR (51.3%, 74%)], p =0.007} and gingivitis
biopsies {63% [IQR (55%, 74%)], p =0.02}. The transcriptional level of IFNG in periodontitis
biopsies was 1.96-fold and significantly higher than tissues with periodontal health (p =0.04).
Although the mRNA level from experimental gingivitis samples exhibited an 8.5-fold increase as
compared with periodontally healthy samples, no significant methylation difference was observed
in experimental gingivitis sample.
Conclusions—A hypomethylation profile within IFNG promoter region is related to an increase
of IFNG transcription present in the chronic periodontitis biopsies, while such an increase of
IFNG in experimentally induced gingivitis seems independent of promoter methylation alteration.
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The fundamental mechanisms that lead to the development of periodontal diseases are
closely related to the dynamics of the host immune and inflammatory responses to
periodontal pathogens present in the dental biofilm (Gemmell & Seymour 2004). Although
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much is known regarding the innate immune response in periodontal disease, the specific
role of T cells in modulating local Th1 and Th2 responses is not fully characterized. Cell-
mediated immunity modulated by a Th1 response, which involves interferon gamma (IFN-γ)
production and interleukin (IL)-2, and the humoural immune response, which is favoured by
a Th2 response and driven by the secretion of IL-4, IL-6 and IL-10, are well established and
these responses have been described in periodontal diseases (Yamazaki et al. 1994, Aramaki
et al. 1998, Dutzan et al. 2009, Gemmell & Seymour 2004, Wright et al. 2008).
The expression of IFN-γ is noteworthy, because of not only its elevated transcriptional and
translational expression in inflamed gingival tissues and gingival crevicular fluid (GCF) but
also its association with advanced periodontal disease and disease progression (Gemmell &
Seymour 2004, Salvi et al. 1998, Takeichi et al. 2000). In a recent molecular epidemiologic
study with 6768 community-based subjects, Offenbacher et al. (2007) reported a significant
increase in the GCF concentration of IFN-γ in those subjects with deep periodontal pockets
and severe gingival bleeding as compared with subjects with probing depth (PD) of <3 mm.
It was demonstrated previously that a high level of Th1 cytokines was found in the GCF of
patients with extremely severe periodontits (terminal dentition stage), including a 10-fold
increase in the concentration of IFN-γ when compared with the Th2 mediators IL-4 and IL6
(Salvi et al. 1998). The presence of high IFN-γ level is shown to enhance the phagocytic
activity of monocytes and neutrophils, which helps containment of infection (Gemmell &
Seymour 2004) as well as upregulates monocytic response to LPS, which results in elevated
monocytic secretion of proinflammatory molecules, such as PGE2, IL-1β and TNF-α, all of
which play important roles in bone loss and the disintegration of soft tissue in the
periodontium (Salvi et al. 1998, Nichols & Garrison 1987). The literature demonstrates that
IFN-γ can be secreted by type-1 CD4+, CD8+ T lymphocytes, NK cells, mononuclear cells
and dendritic cells found in periodontal tissues (Takeichi et al. 2000, Fujihashi et al. 1996).
However, the molecular signalling pathways that result in a chronically elevated level of
IFN-γ expression in periodontal diseases are still the subject of investigation.
The control of inflammatory responsiveness by the host to the recurrent and omnipresent
challenges imposed by the oral biofilm is complex, involving genetically determined traits,
regulation by cytokine networks and changes in epigenetic patterns. For example, genetic
studies suggest that specific single nucleotide polymorphism (SNP) haplotypes of IL1B in
the population are associated with the level of IL-1β within the GCF (Rogus et al. 2008).
IL-12 has been shown to potently enhance IFNG expression (Watford et al. 2003). Recently,
alterations in epigenetic patterns have been discovered as another important mechanism for
the regulation of gene expression at mucosal surfaces (Nakajima et al. 2009). In eukaryotes,
DNA methylation occurs almost exclusively at the 5′ end of cytosine nucleotide within the
CpG dinucleotide context (Bird & Wolffe 1999). The change of methylation status in CpG
islands, which are regions of genome that contain a high percentage of CpG dinucleotides,
are profoundly associated with diseases such as developmental abnormalities, cancer and
chronic inflammatory states (Bird 2002, Barros & Offenbacher 2009). It has been generally
accepted that an increased methylation (hypermethylation) in the gene promoter region is
associated with a decrease of gene expression, while a hypomethylation pattern is closely
associated with transcriptional upregulation (Jones & Laird 1999, Shuto et al. 2006).
Recently, we have described an increased methylation of CpG islands within the PTGS2
promoter region in human gingival biopsies associated with a suppression of PGE2 mRNA
expression (Zhang et al. 2010).
The aim of this study is to understand whether IFN-γ expression in the gingival tissues from
subjects with different stages of periodontal diseases, including experimentally induced
gingivitis and chronic periodontitis, is associated with an altered methylation status of the
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promoter region of IFNG, as evaluated in the context of IFNG SNPs known to regulate
expression levels.
Materials and Methods
Participants, experimental gingivitis and tissue specimens
A total of 47 participants, aged between 19 and 63 years, provided informed consent and
were enrolled into this study wherein all components were approved by the Institutional
Review Board (IRB) of the University of North Carolina at Chapel Hill. Exclusion criteria
for recruiting participants exhibiting chronic periodontitis and periodontal health included:
(1) the use of either antibiotics or non-steroidal anti-inflammatory drugs within 1 month
before scheduled surgery; and (2) medical treatment for other diseases 3 months before
recruitment. Measurements included PDs, clinical attachment levels (CAL), and bleeding on
probing (BOP) at six sites per tooth. One interproximal gingival site was biopsied from each
participant. Twelve gingival biopsies were removed during routine periodontal flap surgeries
from participants clinically diagnosed with chronic periodontitis. Scaling and root planing as
initial therapy were performed on those patients four to six weeks before periodontal
surgeries. Those biopsied tissues were from sites exhibiting PDs of 5 mm or more, BOP and
radiographic evidence of localized bone loss. Twenty-three gingival tissues were collected
from different participants who were periodontally healthy or had localized mild gingivitis
at non-study sites. These gingival biopsies were removed from either periodontally healthy
volunteers or participants who were undergoing crown lengthening procedures at sites with
PD measurements of 4 mm or less at all six interproximal probing sites, no BOP and no
evidence of radiographic bone loss.
Another 12 biopsied samples were collected from different participants exhibiting
experimental gingivitis. The gingivitis was induced following a 21-day stent-induced
biofilm overgrowth protocol as described previously (LOE et al. 1965). In addition to the
exclusion criteria mentioned above, all participants had at least four teeth in each posterior
sextant. In this protocol, gingivitis participants with BOP scores of ≥10% (Loe et al. 1986)
and pocket depth probing <5 mm were brought to periodontal health by initial dental
prophylaxis and supragingival scaling. After 1 week following this treatment, baseline GI
scores were collected and the subjects were instructed to wear two stents during routine
toothbrushing and not to floss the stent-covered teeth. This stent covered the tooth surfaces
and promoted biofilm overgrowth during a 3-week induction period. At day 21, biopsies
were collected from one interproximal site of gingiva in one of the stent sextants.
Upon removal, all biopsied gingival tissues were divided into two comparable samples. One
half, used for DNA methylation analysis, was kept in the − 80°C freezer immediately, while
the other half, used for real-time polymerase chain reaction (RT-PCR), was incubated with
RNA later (Applied Biosystems/Ambion, Austin, TX, USA) overnight at 4°C, and then
transferred to −80°C.
DNA isolation and sodium bisulphite conversion
Genomic DNA was isolated from collected gingival tissue samples using a DNeasy Mini Kit
(Qiagen, Valencia, CA, USA) according to manufacturer’s instructions. Genomic DNA was
bisulphite treated using published procedures (Grunau et al. 2001). Briefly, 1–2 μg of
genomic DNA in 45 μl of nuclease-free water was denatured at 42°C for 20 min. with 5 μl of
freshly prepared 3 M sodium hydroxide. Denatured DNA was incubated with freshly
prepared sodium bisulphite (saturated) and hydroquinone solution in the water bath at 55°C
for 16 h. The bisulphite-converted DNA was purified using a Wizard DNA Clean-up
Column (Promega, Madison, WI, USA) and then desulphonated by incubation with 5.5 μl of
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a 3 M NaOH solution at 37°C for 20 min. The bisulphate-treated DNA was finally
precipitated with ethanol, and then redissolved in 25 μl of 1 mM Tris-Cl pH 8.
Bisulphite specific PCR and pyrosequencing
The detailed information of primers used in the bisulphite-specific PCR can be found in
Table 1. For methylation analysis, five amplicons, which were amplified by using a HotStar
Taq kit (Qiagen), include a total of six CpG sites within the proximal promoter region of
IFNG. PCR conditions for each individual amplicon, in which specific CpG sites were
included, can be found in Table 2. Direct quantification of the ratio of methylated to
unmethylated cytosine nucleotide for each analysed CpG site present in the amplicons was
determined by pyrosequencing with the PSQ HS 96 Pyrosequencing System (Qiagen) and
Pyro Gold CDT Reagents (Qiagen) as described previously (Colella et al. 2003). We have
also checked a polymorphism at site −179 bp in the same amplicon containing the CpG site
of − 186 bp by pyrosequencer. In each pyrosequencing assay, one amplicon was used for
sequencing and the corresponding sequencer can be found in Table 1. Internal controls for
bisulphite conversion efficiency were included in each pyrosequencing assay. A genomic
sequence that is artificially methylated on all its CpG dinucleotides (Cat. # S7821, Millipore,
Billerica, MA, USA) was also used in the bisulphite conversion, PCR and pyrosequencing
with the primers and sequencers mentioned above as a technical control.
Quantitative real time PCR
Total RNA was isolated from gingival tissues with the use of an RNeasy Mini Kit (Qiagen).
cDNA from 500 ng of total RNA was synthesized using an Omniscript Kit (Qiagen) and
random decamer primers (Cat. # 5722E, Austin, TX, USA). Real-time PCR was performed
with 1 μl of synthesized cDNA, 12.5 μl TaqMan Universal PCR mix, and 1.25 μl 20X assay
on demand gene expression assay mix (Mm00445273_m1, Applied Biosystems, Foster City,
CA, USA), in a 7000 Sequence Detection System (ABI Prism, Applied Biosystems). Each
sample was performed in duplicates. The ribosomal 18S Control Reagents (part no.
4308329), which was also from Applied Biosystems, was used as an endogenous control for
data normalization. The relative quantity of IFNG mRNA was calculated against 18S rRNA
values according to the method recommended by Livak & Schmittgen (2001).
Immunofluorescence
After sectioning, the frozen gingival tissues from healthy gingival and chronic periodontitis
tissues were fixed with 70% ethanol for 15 s and followed by acetone for another 5 min.
Then, the frozen tissue slides were blocked for 1 h at room temperature, and then incubated
overnight at − 4°C with monoclonal antibodies specific for CD4 (Cat. #14-0049,
eBioscience, San Diego, CA, USA), CD11C (CAt.# 14-0116, eBiosciences) CD56 (Cat.#
14-0567, eBioscience). All the antibodies except for anti-CD4 were 1:50 diluted in a
blocking buffer containing 8% bovine serum albumin, 1% goat serum and 1% Triton-X-100.
Anti-CD4 antibody was 1:20 diluted with the same blocking buffer. After vigorous washing
with 1 × PBS containing 0.1% Triton-X-100 the slides were incubated for 1 h at room
temperature with a secondary antibody, Alexa Fluor 488 goat anti-mouse IgG (Molecular
Probes, Invitrogen, Carlsbad, CA, USA). Sections were then washed in 0.1% Triton/PBS,
mounted with ProLong Gold antifade reagent with DAPI (Invitrogen) and coverslipped.
Sections were analysed using confocal microscopy (Carl Zeiss LSM 710 Confocal
Microscope, Thornwood, NY, USA).
Statistical analysis
Analysis of variance was applied for the statistical analysis of clinical measurement. Fisher’s
exact test was used to test gender difference among participants in different groups. Mann–
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Whitney/Wilcoxon two-sample test was used to compare the methylation level of each CpG
site and the overall percent methylation of gingival samples among different biopsy groups.
Linear regression analysis was applied for testing for significance of the slope to analyse the
IFNG messenger level of different sample groups. The threshold for all statistical
significance was set at a p-value <0.05.
Results
Selected characteristics between the three subsets of individuals are summarized in Table 3.
There were no age differences between periodontally diseased subjects (either periodontitis
or experimental gingivitis) and participants with periodontal health. As expected, in the
periodontitis tissue group, both PD and CAL were greater than the periodontal health group
(p<0.001 for both). Although there were more male participants in chronic periodontitis
group as compared with the periodontal health group (p =0.01), there is no evidence so far
that gender has a differential effect on methylation status of the IFNG promoter in
periodontal diseases.
The positions of all six analysed CpG sites within the promoter region of the IFNG gene are
depicted in Fig. 1. Because the methylation pattern of the CpG sites shown in this region has
been demonstrated to be mechanistically related to the control of IFN-γ expression in
various studies (White et al. 2002,White et al. 2006,Gonsky et al. 2009), we performed
DNA methylation analysis on these CpG sites in our biopsied gingival tissues.
Figure 2 demonstrates two representative sequencing pyrograms of the methylation level of
the IFNG promoter region taken from a periodontally healthy and a chronic periodontitis
sample. The pyrogram in Fig. 2a shows that, at the CpG dinucleotide at position −295 bp,
71% of the amplification products from one healthy gingival tissue sample contained a
methylated cytosine nucleotide (Fig. 2a). The pyrogram in Fig. 2b demonstrates that at
position −295 bp, 49% of the amplification products from one periodontitis tissue sample
contained a methylated cytosine residue (Fig. 2b).
A lower level of methylation as determined by pyrosequencing was found at each individual
CpG site within the IFNG promoter region in the DNA samples from the chronic
periodontitis tissues as compared with tissues with periodontal health (Fig. 3a). Of all the
analysed CpG dinucleotides, the methylation levels at site −295 bp, − 54 bp and +171 bp
from the chronic periodontitis DNA samples were significantly lower than the healthy
gingival samples {44.5% [inter-quartile range, IQR (37%, 50.5%)] versus 60% [IQR
(51.5%, 64.5%)], p =0.002 for site −295 bp, 58.5% [IQR (55.3%, 62%)] versus 65% [IQR
(58.5%, 71%)], p =0.04 for site − 54 bp, and 49% [IQR (47.5%, 50.3%)] versus 55% [IQR
(52.5%, 59%)], p =0.0007 for site +171 bp}. In contrast, there is no significant difference of
DNA methylation percentage in each analysed CpG site in the experimentally induced
gingivitis group as compared with periodontal health samples. One of the designed
amplicons encompassing one methylation site at −186 bp also contained a reported SNP at
position − 179 bp. The G/T SNP (rs2069709) reported at site −179 bp is reported to be
associated with an elevated level of IFNG gene expression (Smith & Humphries
2009,Bream et al. 2002). We examined this polymorphism for all the samples along with
DNA methylation analysis. No minor allele (− 179T) was detected in any of the analysed
samples (data not shown).
The overall median methylation percentage of all the six CpG sites within IFNG promoter
was 52% [IQR (43.8%, 63%)] in the chronic periodontitis biopsies and significantly lower
than the methylation percentage in samples with periodontal health and experimental
gingivitis biopsies, which were 62% [IQR (51.3%, 74%)] (p =0.007) and 63% [IQR (55%,
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74%)] (p =0.02), respectively (Fig. 3b). No significant difference can be found in the IFNG
promoter methylation levels comparing samples with periodontal health with samples with
experimental gingivitis.
Because DNA methylation level is a critical regulatory mechanism for gene transcription,
we also measured the messenger (mRNA) level of IFNG in biopsied tissues. The
transcriptional level of IFNG was 1.96-fold increased and significantly higher in the
periodontitis biopsy samples compared with the healthy gingival samples as determined by
quantitative real-time PCR (p =0.04, Fig. 4). In contrast, there was an 8.5-fold induction of
IFNG transcription in experimentally induced gingivitis samples as compared with samples
with periodontal health, and this increase of messenger level was statistically significant (p
=0.01).
We also performed an immunofluorescence experiment to identify the IFN-γ-secreting cell
populations and compare them between chronic periodontitis samples and tissues with
periodontal health. In chronic periodontitis tissues more CD4+ T cells were present in the
epithelial and lamina propia as compared with the tissues with periodontal health (Fig. 5a
and b). In addition, we also found more CD56+ (Fig. 5c and d) and CD11C (data not shown)
cells, which are markers for NK and dendritic cells, respectively, infiltrated in the
chronically diseased biopsies than samples in healthy gingival tissues.
Discussion
Although B-cell mediated adaptive immune responses dominate in chronic periodontitis,
differential distribution of Th1 or Th2 cytokine secretion profiles have been reported to be
related to the severity and/or progression of periodontal diseases (Salvi et al. 1998, Garlet et
al. 2003). Among the Th1 cytokines, IFN-γ plays a central role in the containment of
infection and represents one of the most efficient cytokines for triggering antimicrobial
activity in both macrophages and neutrophils (Huang et al. 1993, Meda et al. 1994, Farrar &
Schreiber 1993). In addition to priming the antimicrobial activities of phagocytes,
overexpression of IFN-γ levels may also lead to direct and indirect host tissue destruction
through the activation of these phagocytes (Boehm et al. 1997).
In our study, we noted a significant 1.96-fold increase in IFN-γ messenger levels in
chronically inflamed periodontal biopsies as compared with periodontally healthy samples,
consistent with several earlier reports (Offenbacher et al. 2007, Dutzan et al. 2009). Studies
have shown an increased IFN-γ level within the GCF and higher IFN-γ expression in
gingival tissues from progressive periodontal lesions (Dutzan et al. 2009). By contrast, other
studies have suggested that elevated IFN-γ is a characteristic of the stable periodontal lesion
and that active lesions favour a Th2 cell response (Lappin et al. 2001, Gemmell et al. 2002,
Reinhardt et al. 1989). We also found that the transcriptional level of IFNG was 8.5-fold
higher in the experimentally induced gingivitis samples as compared with tissues with
periodontal health. Such a more pronounced transcriptional expression seems independent of
IFNG methylation in the analysed promoter region. Although the inflammatory lesion from
experimental gingivitis is histologically similar to the chronic periodontitis in that
inflammatory infiltrates dominated by lymphocytes and antigen-presenting cells such as
macrophage and dendritic cells are noticeably present (Zachrisson 1968, Seymour et al.
1988), the mechanisms for IFN-γ production may be possibly different in the different stages
of periodontal diseases. For example, a cytokine-dominating mechanism such as high IL-12
secretion from antigen-presenting cells and IL-18 may be possibly responsible for the
observed high-level production of IFN-γ in Th1-committed cells in experimental gingivitis
lesions (Yang et al. 1999, Berenson et al. 2004). In addition, p38 and JNK signalling
pathways have also been shown to be critically involved in IFN-γ production (Lu et al.
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2001). However, this study supports that a decreased methylation profile within the IFNG
promoter region may contribute to a higher gene transcriptional level, as found in
chronically diseased gingival tissues. We hypothesized here that the promoter region of
IFNG in infiltrating Th1 cells may be already epigenetically modified before migration into
the lesion after prolonged and systemic exposure to periodontal pathogens present in the oral
biofilm in chronic periodontitis patients.
It has been extensively reported that genetic polymorphisms can regulate cytokine
expression levels. Bream et al. (2002) reported a guanidine to thymidine transition at site
−179bp (G/T) within the IFNG proximal promoter; these authors reported that, as compared
with −179G allele, the − 179T allele exhibited a 6–13-fold increase in the expression of
IFNG in a promoter assay. The absence of SNP at position −179 bp within the IFNG
promoter in all the gingival biopsies analysed by pyrosequencing supports the argument that
the differences in IFNG expression in the chronic periodontitis biopsies were less likely
attributable to IFNG polymorphisms, but more likely due to epigenetic influences conferred
by prolonged environmental exposures.
In this study, the general demethylation pattern across all six CpG sites within the IFNG
promoter region in the periodontal lesions could be due to chronic inflammation or the direct
action and/or invasion of periodontal pathogens. Hypomethylation in chronically diseased
gingival tissues could reflect a dilution of the tissue DNA pool by an influx of non-
methylated DNA-bearing cells or the loss of methylation from the resident cells. We have
found that more CD4+ T cells, CD11C+ cells and CD56+ NK cells infiltrated in the
periodontitis gingival samples than tissues in healthy gingival samples. Therefore, the
observed lower methylation pattern in the IFNG promoter region in periodontitis may be
associated with altered methylation patterns on those cells capable of IFN-γ production.
Nares et al. (2009) showed a marked infiltration by various inflammatory cell types in
periodontally inflamed tissues in comparison with healthy gingival tissues, and also
demonstrated that IFN-γ immunostaining was related to the presence of monocytes,
macrophages and lymphocytes in periodontally diseased tissues. This evidence is consistent
with our hypothesis that in periodontally diseased gingival tissues, hypomethylation status
of IFNG promoter in these inflammatory cell types contributes to the observed higher IFN-γ
expression in comparison with healthy gingival tissues. This association has also been
reported and discussed by others; Gonsky et al. (2009), examining patients with
inflammatory bowel disease, collected intestinal specimens from patients undergoing
surgical resection of the colon, and showed that the infiltrated T cells isolated from the
lamina propria in the mucosal tissues exhibited lower level of IFNG methylation in
comparison with T cells isolated from peripheral blood from the same patients, suggesting
that the epigenetic methylation status of IFNG plays a mechanistic role in the modulation of
IFNG secretion in the mucosa. In another recent study on the methylation levels of IFNG
promoter in human dental pulp tissues, the authors found an elevated level of
hypomethylation in symptomatic pulpitis as compared with control pulp samples from
impacted teeth, and also associated the IFNG hypomethylation levels with an increased
number of infiltrating mononuclear cells in the inflamed tissues (Cardoso et al. 2010).
A hypomethylation pattern of the IFNG promoter region has also been reported by several
groups as the hallmark of T cell commitment to a Th1 phenotype (White et al. 2002, White
et al. 2006, Kwon et al. 2008). In this study, although the methylation level of IFNG from
periodontal lesions is significantly lower than control sites [52% (IQR, 43.8%, 63%) versus
62% (IQR, 51.3%, 74%) p =0.007], the magnitude of the difference (~ 10%) is not large,
probably due to the fact that the modulation of methylation patterns of IFN-γ-competent cell
populations, which are infiltrated inflammatory cells, constitute a relatively small percentage
of the total cell numbers within the periodontal lesion. Therefore, the magnitude of
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methylation difference between chronic periodontitis biopsies and gingival tissue with
periodontal health would be expected to be relatively small, diluted by the overwhelming
presence of non-IFN-γ competent cell populations in the tissue. However, this small
decrease in methylation can account for a greater induction of messenger level of IFNG
because it may be targeted to the IFN-γ-producing cells. Gonsky et al. (2009) reported that a
5% lower methylation level observed in the IFNG promoter region of lamina propria T cells
from patients with inflammatory bowel disease as compared with controls was associated
with an almost 3-fold induction of IFNG transcription. Thus, the difference of the IFNG
methylation level that we observed in the oral mucosa is in close agreement with the levels
observed in inflammatory bowel disease. However, the causal relationship between a small
change of methylation in the promoter region of IFNG and an increase of its transcription
level requires further mechanistic evidence supported by experiments such as chromatin
immunoprecipitation, electrophoretic mobility shift assay, etc.
The findings from this study indicate the potential role of local epigenetic effects that result
in regional modifications of the tissue DNA methylation status in the pathogenesis of
chronic inflammatory periodontal disease. The observed hypomethylation of the IFNG
promoter is a characteristic of a chronic inflammatory state. The study of methylation in
inflamed tissues under chronic infection is still at an early stage and altered methylation
patterns likely affect many genes in disease. Additional research is needed to elucidate the
potential diagnostic utility of epigenetic markers as a determinant of disease progression, as
well as response to treatment. Because the DNA methylation status can be modified by
certain drugs, the possibility of reversing epigenetic modifications may have profound
effects on periodontal treatment responses.
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Diagrammatic representation of the IFNG promoter region (GeneBank accession no.
J00219). “ “ indicates CpG dinucleotide sequences that can be potentially methylated. The
position of each CpG dinucleotide site is illustrated in relation to the transcription start,
which is indicated as “+1” bp.
Zhang et al. Page 12














Representative programs of pyrosequencing. The percentage on each CpG site is the
methylation percentage of mC/(mC+C) on that site. mC, methylated cytosine; C,
unmethylated cytosine. The sequence shown on the top of each panel is the assayed
sequence. The x-axes are the dispensation nucleotides to the sequencing reaction based on
the assayed sequences. The y-axes show light emission obtained as relative light units. The
methylation percentage of one specific CpG site (− 295 bp) from a healthy gingival biopsy
sample (a), which shows the value of methylation percentage of 71, and a chronic
periodontitis sample (b), which shows a value of methylation percentage of 49 are
illustrated. This percentage is calculated from the reference peak heights, marked as dark
diamonds, which are non-CpG nucleotide sequences. The red diamond marks indicate
“built-in” bisulphite controls in pyrosequencing.
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(a) The percentage of methylation in each individual CpG site from healthy gingival tissues,
experimental gingivitis and chronic periodontitis biopsies. *,**,***Significantly lower
methylation level in chronic periodontitis biopsies than in healthy samples at CpG site −54
(p =0.04), CpG site −295 (p =0.002) and CpG site +171 (p =0.0007), respectively. Plus error
bars and minus error bars demonstrate the maximal and minimal methylation percentages,
respectively, while the top line, middle line and the bottom line of boxes illustrate 75th
percentile, median and 25th percentile of the methylation levels in each group analysed,
respectively. (b) Percentage of overall methylation level combining all six analysed CpG
sites within the IFNG promoter region in biopsied tissues exhibiting periodontal health,
experimental gingivitis and chronic periodontitis. “**” and “*” indicate that the overall
methylation level of IFNG promoter region in chronic periodontitis gingival tissues was
statistically lower than the percentage of methylation in healthy tissues (p =0.007) and
experimental gingivitits biopsies (p =0.02), respectively. The top, middle and bottom lines
of the box plot indicate the 75th percentile, median and 25th percentile methylation levels,
respectively. Plus error bars and minus error bars demonstrate the maximal and minimal
methylation percentages, respectively.
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mRNA expression levels of IFNG in the healthy gingival biopsies, experimental gingivitis
and chronic periodontitis samples. Fold induction is shown using 18S as an internal
housekeeping gene. As compared with gingival biopsies with periodontal health, a 1.96-fold
increase in the transcriptional level of IFNG is significantly higher (p =0.04) in the chronic
periodontitis biopsies, which was indicated by “*”. In contrast, the transcriptional level of
IFNG in experimental gingivitis showed an 8.5-fold increase and was significantly higher (p
=0.01) than tissues with peridontal health, which was indicated by “**”.
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Immunofuorescence staining of CD4+ and CD56+ cells in one representative chronic
periodontitis biopsy and one biopsy with periodontal health. (a) and (b) Biopsy section from
either a site with chronic periodontits (a) or a site with periodontal health (b) showing CD4+
(green) T cells within the gingival epithelium and lamina propria. (c) and (d) A chronic
periodontitis (c) and a healthy gingival tissue (d) were stained for CD56+ (green) NK cells.
Nuclei were stained with DAPI (blue).
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Table 1
Oligonucleotides used for bisulphite-specific polymerase chain reaction and pyrose-quencing






















CpG sites indicate nucleotide position in relation to transcription start.
“−” or “+”, indicates upstream or downstream of transcription start, respectively.
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Table 3
Demographic information of the participants and clinical parameters in the biopsied gingival sites
Demographic/Clinical parameters Periodontal health (n =23) Experimental gingivitis (n =12) Periodontitis (n =12)
Mean age (years) 40.8 ± 11.6 35.8 ± 11.2 47.2 ± 7.4
Gender
Males/Females 6/17 5/7 9/3*
Probing depth (Mean±SD, mm) 2.2 ± 0.6 2.24 ± 0.63 6.3 ± 0.8**
Clinic attachment level (Mean±SD, mm) 1.2 ± 0.6 1.3 ± 0.45 4.7 ± 1.5**
*
p<0.05 as compared with periodontal health.
**
p<0.001 as compared with periodontal health.
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